RLLVF (Relevium Technologies) Effective Interest Rate on Debt %: 2.23% (As of Mar. 2022)


What is Relevium Technologies Effective Interest Rate on Debt %?

Relevium Technologies RLLVF -99.98% Effective Interest Rate on Debt % is 2.23% as of Mar. 2022.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Relevium Technologies's annualized positive value of Interest Expense for the quarter that ended in Mar. 2022 was $0.02 Mil. Relevium Technologies's average total debt for the quarter that ended in Mar. 2022 was $1.08 Mil. Therefore, Relevium Technologies's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2022 was 2.23%.

Relevium Technologies  (OTCPK:RLLVF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Relevium Technologies Effective Interest Rate on Debt % Related Terms

Relevium Technologies Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Relevium Technologies's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relevium Technologies Effective Interest Rate on Debt % Chart

Relevium Technologies Annual Data
Trend Dec12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 25.23 14.17 20.19 26.23

Relevium Technologies Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.65 74.14 18.27 6.97 2.23

RLLVF vs HEWA, SSY: Effective Interest Rate on Debt % Comparison

For the Pharmaceutical Retailers subindustry, Relevium Technologies's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relevium Technologies Effective Interest Rate on Debt % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Relevium Technologies's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Relevium Technologies's Effective Interest Rate on Debt % falls into.


Relevium Technologies Effective Interest Rate on Debt % Calculation

Relevium Technologies's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jun. 2020 )+Total Debt  (A: Jun. 2021 ))/ count )
=-1  *  -0.615/( (2.074+2.616)/ 2 )
=-1  *  -0.615/2.345
=26.23 %

where

Total Debt  (A: Jun. 2020 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 2.074
=2.074

Total Debt  (A: Jun. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 2.616
=2.616

Relevium Technologies's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2022 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2021 )+Total Debt  (Q: Mar. 2022 ))/ count )
=-1  *  -0.024/( (0.992+1.164)/ 2 )
=-1  *  -0.024/1.078
=2.23 %

where

Total Debt  (Q: Dec. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 0.992
=0.992

Total Debt  (Q: Mar. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 1.164
=1.164

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2022) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 2.23% mean?
Relevium Technologies (RLLVF) has a Effective Interest Rate on Debt % of 2.23% as of Mar. 2022. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Relevium Technologies and its competitors.
Is Relevium Technologies' Effective Interest Rate on Debt % too high?
Relevium Technologies' current Effective Interest Rate on Debt % is 2.23%.
How does Relevium Technologies' Effective Interest Rate on Debt % compare to HEWA and SSY?
Relevium Technologies' Effective Interest Rate on Debt % of 2.23% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Healthcare Providers & Services company?
A good Effective Interest Rate on Debt % depends on the Healthcare Providers & Services industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Relevium Technologies and its competitors. Relevium Technologies's current Effective Interest Rate on Debt % is 2.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relevium Technologies stock overvalued right now?
Relevium Technologies (RLLVF) has a current Effective Interest Rate on Debt % of 2.23%. The current Effective Interest Rate on Debt % is 2.23%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Relevium Technologies (RLLVF), the current Effective Interest Rate on Debt % is 2.23% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Relevium Technologies Business Description

Address 1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.